Stock UniverseDerived research view · source repositories remain read-only

Celcuity Inc. (CELC)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.68
Global Rank
446
Market Cap
5.17B
Latest Close
88.28
RS Composite
-27.46% · G#2941

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-36.69%
3M
-23.23%
6M
-11.72%
1Y
636.89%
3Y
717.03%
5Y
225.88%
10Y
517.77%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.66M · 30-day average: 1.60M · Max drawdown over stored range: -85.64%

Research Snapshot

Relative Strength vs SPX

RS Composite-27.46%
20D RS-33.10%
60D RS-32.71%
120D RS-19.39%
Global RS Rank2941 · 12.34% percentile
Qualified+ RS Rank1137 · 9.62% percentile
Group ScopeQualified+
Primary RS Rank349 · 23.80% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank48 / 701
Primary Percentile93.30
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-03-26n/an/a-172.19M-177.04M-3.79-261.20M408.00K-261.61M47Mn/an/an/an/an/a441.50M137.55M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$-3.79-23.3xn/an/a$-5.60-15.8x$-5.59-15.8x

Shares Diluted: 47M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-9.5562-28.3559-39.3911-66.2303-113.267
Free Cash Flow-7.2351-20.3938-36.1669-53.9099-83.7166-153.529
Free Cash Flow Per Share-0.705-1.524-2.346-2.277-2.122-3.2835026006737587
EPS (Diluted) GAAP-0.922789-2.212228-2.635919-2.693434-2.83348
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)10.266913.382615.418523.679539.449446.7577
Shares Change (YoY)0.399%30.347%15.214%53.578%66.597%18.526%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2025 Q42026-03-26n/an/a-49.20Mn/a-50.97Mn/a-0.9752.68M441.50M137.55Mprocessed
2025 Q32025-11-13n/an/a-42.85Mn/a-43.80Mn/a-0.9247.59M454.98M137.22Mprocessed
2025 Q22025-08-14n/an/a-44.01Mn/a-45.27Mn/a-1.0443.66M168.39M105.59Mprocessed
2025 Q12025-05-15n/an/a-36.13Mn/a-37.00Mn/a-0.8643.05M205.69M105.34Mprocessed
2024 Q42025-03-31n/an/a-36.43Mn/a-36.65Mn/a-0.8542.90M235.10M105.09Mprocessed
2024 Q32024-11-14n/an/a-30.06Mn/a-29.79Mn/a-0.7042.79M264.06M104.84Mprocessed
2024 Q22024-08-14n/an/a-24.28Mn/a-23.72Mn/a-0.6238.44M283.07M104.59Mprocessed
2024 Q12024-05-15n/an/a-22.49Mn/a-21.61Mn/a-0.6433.61M177.66M38.03Mprocessed
2023 Q42024-03-27n/an/a-19.73Mn/a-18.85Mn/a-0.6528.96M180.58M37.57Mprocessed
2023 Q32023-11-13n/an/a-18.90Mn/a-18.40Mn/a-0.8322.12M133.94M37.10Mprocessed
2023 Q22023-08-11n/an/a-15.06Mn/a-14.59Mn/a-0.6621.96M146.24M36.64Mprocessed
2023 Q12023-05-15n/an/a-12.55Mn/a-11.94Mn/an/an/a157.48M36.19Mprocessed
2022 Q42023-03-23n/an/a-11.64Mn/a-11.58Mn/an/an/a168.59M35.76Mprocessed
2022 Q32022-11-10n/an/a-10.64Mn/a-10.89Mn/an/an/a57.48M16.29Mprocessed
2022 Q22022-08-12n/an/a-9.60Mn/a-9.96Mn/an/an/a66.91M16.18Mprocessed
2022 Q12022-05-16n/an/a-7.51Mn/a-7.93Mn/an/an/a78.30M16.08Mprocessed
2021 Q42022-03-23n/an/a-6.32Mn/a-6.75Mn/an/an/a84.29M15.98Mprocessed
2021 Q32021-11-09n/an/a-5.60Mn/a-6.03Mn/an/an/a90.37M15.87Mprocessed
2021 Q22021-08-11n/an/a-13.64Mn/a-14.03Mn/an/an/a41.64M15.77Mprocessed
2020 Q12021-05-10n/an/a-2.79Mn/a-2.79Mn/an/an/a34.94M-5.82Kprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.